Effects of Serratus Anterior Plane Block (SAP), Pectoral Nerve Blocks (PECS I-II), and Standard Systemic Analgesia on Early Postoperative Recovery After Coronary Artery Bypass Grafting
A Prospective, Randomized Controlled Trial Comparing Serratus Anterior Plane Block (SAP), Pectoral Nerve Blocks (PECS I-II), and Standard Systemic Analgesia on Mechanical Ventilation Duration and Postoperative Recovery After Coronary Artery Bypass Grafting
1 other identifier
interventional
243
1 country
1
Brief Summary
The effects of anterior chest wall blocks (PECS and SAP will be used in this study) performed for postoperative analgesia on pain scores (to be checked with visual analogue scale (VAS), opioid consumption, length of hospital stay, mobilization time, side effects and complications in the postoperative period will be examined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started Jun 2023
Typical duration for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2023
CompletedStudy Start
First participant enrolled
June 15, 2023
CompletedFirst Posted
Study publicly available on registry
July 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedMarch 3, 2026
February 1, 2026
11 months
May 23, 2023
February 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Duration of Mechanical Ventilation
Time (in hours) from ICU admission to successful extubation.
Within the first 24 postoperative hours
Secondary Outcomes (6)
Length of Intensive Care Unit (ICU) Stay
Assessed once at the time of ICU discharge, measured as total hours from ICU admission to ICU discharge (expected within 30 postoperative days).
Postoperative Pain Intensity at Rest (VAS)
Assessed at 0, 4, 8, 12, and 24 hours after extubation within the first 24 hours post-extubation.
Total Rescue Opioid Consumption (Morphine Equivalents)
Within the first 24 hours after extubation
Time to First Mobilization
Assessed once when first active sitting at bedside is achieved, within 48 hours after ICU admission.
Postoperative Nausea and Vomiting (PONV)
Assessed at 0-24, 24-48, and 48-72 hours after extubation during postoperative ICU and ward follow-up.
- +1 more secondary outcomes
Study Arms (3)
Group S - Serratus Anterior Plane Block
EXPERIMENTALPatients received an ultrasound-guided serratus anterior plane (SAP) block with 30 mL of 0.25% bupivacaine within the first 30 minutes after ICU admission in addition to standardized systemic analgesia.
Group P - Pectoral Nerve Block (PECS I-II)
EXPERIMENTALPatients received ultrasound-guided PECS I-II block with a total of 30 mL of 0.25% bupivacaine within the first 30 minutes after ICU admission in addition to standardized systemic analgesia.
Group C - Standard Systemic Analgesia
ACTIVE COMPARATORPatients received standardized multimodal systemic analgesia without any regional block. Postoperative analgesia consisted of scheduled intravenous paracetamol and rescue opioid administration as needed.
Interventions
Standard postoperative multimodal systemic analgesia without regional nerve block. Postoperative analgesia includes scheduled intravenous paracetamol and rescue opioid administration as needed.
Serratus anterior plane block
Eligibility Criteria
You may qualify if:
- Agreeing to participate in the study,
- years old
- ASA I-II-III
- Open heart surgery
You may not qualify if:
- Refusal to participate in the study
- years old, over 65 years old
- Pregnancy
- Presence of bleeding diathesis
- Liver or kidney failure
- Receiving effective treatment on immunity
- Immune suppressed
- Those with BMI ≥30
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Van Yuzuncu Yil University
Van, Turkey, 65100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
School of Medicine Department of Anesthesiology and Reanimation
Yuzuncu Yil University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants and outcome assessors were blinded to group allocation. The anesthesiologist performing the regional block was not blinded. ICU clinicians responsible for extubation decisions were unaware of treatment allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 23, 2023
First Posted
July 25, 2023
Study Start
June 15, 2023
Primary Completion
April 26, 2024
Study Completion
November 1, 2024
Last Updated
March 3, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
participiants's personal information will not be shared anyone